FatiguE in Sjögren’s Syndrome: a randomised controlled trial of cOmbined Non-phArmacological therapeutic strategies (FESSONA)
Xinyao Zhou(Université Claude Bernard Lyon 1), Martin Killian(Université Claude Bernard Lyon 1), Claire Colas(Inserm), David Hupin(Inserm), Jinzhou Chen(Meizhou City People's Hospital)
Cited by 3
Related Papers
Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged ≥60 years: a systematic review and meta-analysis
|British Journal of Sports Medicine|2015|566
Management of Long COVID—The CoviMouv' Pilot Study: Importance of Adapted Physical Activity for Prolonged Symptoms Following SARS-CoV2 Infection
|Frontiers in Sports and Active Living|2022|39
Physical Activity in Long COVID: A Comparative Study of Exercise Rehabilitation Benefits in Patients with Long COVID, Coronary Artery Disease and Fibromyalgia
|International Journal of Environmental Research and Public Health|2023|35
Understanding Experiences of Fibromyalgia Patients Involved in the Fimouv Study During COVID-19 Lockdown
|Frontiers in Psychology|2021|29